KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Aurinia Pharmaceuticals (AUPH) Return on Invested Capital: 2020-2025

Historic Return on Invested Capital for Aurinia Pharmaceuticals (AUPH) over the last 1 years, with Sep 2025 value amounting to 0.16%.

  • Aurinia Pharmaceuticals' Return on Invested Capital was N/A to 0.16% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.16%, marking a year-over-year change of. This contributed to the annual value of -0.01% for FY2024, which is N/A change from last year.
  • Aurinia Pharmaceuticals' Return on Invested Capital amounted to 0.16% in Q3 2025, which was up 33.04% from 0.12% recorded in Q2 2025.
  • Aurinia Pharmaceuticals' 5-year Return on Invested Capital high stood at 0.16% for Q3 2025, and its period low was -0.01% during Q4 2024.
  • For the 2-year period, Aurinia Pharmaceuticals' Return on Invested Capital averaged around 0.09%, with its median value being 0.09% (2025).